Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | PPM1B | O75688 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.32 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PPP5C | P53041 | 1/20 | 0.32 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14236960 | 0.88 | ALDH1A1 (0.32) | SMN1; SMN2 | |
| SCHEMBL21500160 | 0.78 | KDM4E (0.41) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL5192078 | 0.77 | — | — | |
| SCHEMBL9531867 | 0.76 | CHRM2 (0.33) | CYP2D6 | |
| SCHEMBL3781685 | 0.73 | PPM1B (0.36) | KDM4EPPM1BRAB9ASMN1; SMN2TP53 | |
| SCHEMBL23418371 | 0.71 | KDM4E (0.35) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL3187300 | 0.71 | KDM4E (0.35) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL3187298 | 0.71 | KDM4E (0.35) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL19441377 | 0.71 | KDM4E (0.35) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL18193415 | 0.71 | KDM4E (0.35) | KDM4EGMNNPPM1BLMNAPPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2535324-B1 | 5-NORBORNENE-2-SPIRO- A-CYCLOALKANONE- A'-SPIRO-2''-5''-NORBORNENE AND METHOD FOR PRODUCING SAME | JX NIPPON OIL & ENERGY CORP (JP) | 2018-11-14 | — | — | EP | disclosed |
| EP-3135670-A1 | TETRACARBOXYLIC DIANHYDRIDE, POLYAMIC ACID, POLYIMIDE, METHODS FOR PRODUCING SAME, AND POLYAMIC ACID SOLUTION | JX Nippon Oil & Energy Corporation (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170044322-A1 | TETRACARBOXYLIC DIANHYDRIDE, POLYAMIC ACID, POLYIMIDE, METHODS FOR PRODUCING THE SAME, AND POLYAMIC ACID SOLUTION | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
| US-9456495-B2 | Norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic dianhydride, norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic acid and ester thereof, method for producing norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic dianhydride, polyimide obtained by using the same, and method for producing polyimide | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2016-09-27 | — | — | US | disclosed |
| EP-2535341-B1 | NORBORNANE-2-SPIRO- A-CYCLOALKANONE-A '-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO- A-CYCLOALKANONE-A '-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO- A-CYCLOALKANONE-A '-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED USING SAME, AND METHOD FOR PRODUCING POLYIMIDE | JX NIPPON OIL & ENERGY CORP (JP) | 2015-08-26 | — | — | EP | disclosed |
| US-20150086753-A1 | NORBORNANE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-a- CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20150062519-A1 | ALIGNMENT FILM, COMPOSITION FOR FORMING ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | JAPAN DISPLAY INC (JP) | 2015-03-05 | — | — | US | disclosed |
| US-8906474-B2 | Alignment film, composition for forming alignment film and liquid crystal display device | JAPAN DISPLAY INC. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-8629303-B2 | 5-norbornene-2-spiro-α-cycloalkanone-α′-spiro-2″-5″-norbornene and method for producing the same | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-01-14 | — | — | US | disclosed |
| US-20130079490-A1 | NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE | TOKYO POLYTECHNIC UNIVERSITY (JP) | 2013-03-28 | — | — | US | disclosed |
| EP-2535324-A1 | 5-NORBORNENE-2-SPIRO- A-CYCLOALKANONE- A'-SPIRO-2''-5''-NORBORNENE AND METHOD FOR PRODUCING SAME | JX Nippon Oil & Energy Corporation (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-20120310013-A1 | 5-NORBORNENE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2''-5''-NORBORNENE AND METHOD FOR PRODUCING THE SAME | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120088040-A1 | ALIGNMENT FILM, COMPOSITION FOR FORMING ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | MAGNOLIA WHITE CORPORATION (JP) | 2012-04-12 | — | — | US | disclosed |
| JP-2002255955-A | METHOD FOR PRODUCING ALICYCLIC TETRACARBOXYLIC DIANHYDRIDE | NISSAN CHEM IND LTD | 2002-09-11 | — | — | JP | disclosed |
| JP-2001002670-A | ALICYCLIC TETRACARBOXYLIC ACID ANHYDRIDE AND ITS PRODUCTION | NISSAN CHEM IND LTD | 2001-01-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079490-A1 | NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE | PKD2, PKD1, BCKDK | KDM4E 4827/4885GMNN 3869/4885PPM1B 3970/4885 |
| US-20170044322-A1 | TETRACARBOXYLIC DIANHYDRIDE, POLYAMIC ACID, POLYIMIDE, METHODS FOR PRODUCING THE SAME, AND POLYAMIC ACID SOLUTION | MCTS1, ARGLU1, ASS1 | KDM4E 1900/4885GMNN 2197/4885PPM1B 4560/4885 |
| US-20120310013-A1 | 5-NORBORNENE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2''-5''-NORBORNENE AND METHOD FOR PRODUCING THE SAME | NR3C2, NR0B2, NR0B1 | KDM4E 4815/4885GMNN 1878/4885PPM1B 4025/4885 |
| US-20150086753-A1 | NORBORNANE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-a- CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-a-CYCLOALKANONE-a'-SPIRO-2\"-NORBORNANE-5,5\",6,6\"-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE | PKD2, NR3C2, PKD1 | KDM4E 4775/4885GMNN 4036/4885PPM1B 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.